Deals Shaping The Medical Industry, October 2012

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

Medical and industrial products manufacturer Danaher Corp. is acquiring publicly traded IRIS International Inc. (body fluid analysis, sample processing, and early disease detection) for $352mm, or $19.50 per share (a 51% premium). (Sep.)

More from Deal-Making

More from In Vivo